Literature DB >> 24089897

Predicting pathologic tumor response to chemoradiotherapy with histogram distances characterizing longitudinal changes in 18F-FDG uptake patterns.

Shan Tan1, Hao Zhang, Yongxue Zhang, Wengen Chen, Warren D D'Souza, Wei Lu.   

Abstract

PURPOSE: A family of fluorine-18 ((18)F)-fluorodeoxyglucose ((18)F-FDG) positron-emission tomography (PET) features based on histogram distances is proposed for predicting pathologic tumor response to neoadjuvant chemoradiotherapy (CRT). These features describe the longitudinal change of FDG uptake distribution within a tumor.
METHODS: Twenty patients with esophageal cancer treated with CRT plus surgery were included in this study. All patients underwent PET/CT scans before (pre-) and after (post-) CRT. The two scans were first rigidly registered, and the original tumor sites were then manually delineated on the pre-PET/CT by an experienced nuclear medicine physician. Two histograms representing the FDG uptake distribution were extracted from the pre- and the registered post-PET images, respectively, both within the delineated tumor. Distances between the two histograms quantify longitudinal changes in FDG uptake distribution resulting from CRT, and thus are potential predictors of tumor response. A total of 19 histogram distances were examined and compared to both traditional PET response measures and Haralick texture features. Receiver operating characteristic analyses and Mann-Whitney U test were performed to assess their predictive ability.
RESULTS: Among all tested histogram distances, seven bin-to-bin and seven crossbin distances outperformed traditional PET response measures using maximum standardized uptake value (AUC = 0.70) or total lesion glycolysis (AUC = 0.80). The seven bin-to-bin distances were: L(2) distance (AUC = 0.84), χ(2) distance (AUC = 0.83), intersection distance (AUC = 0.82), cosine distance (AUC = 0.83), squared Euclidean distance (AUC = 0.83), L(1) distance (AUC = 0.82), and Jeffrey distance (AUC = 0.82). The seven crossbin distances were: quadratic-chi distance (AUC = 0.89), earth mover distance (AUC = 0.86), fast earth mover distance (AUC = 0.86), diffusion distance (AUC = 0.88), Kolmogorov-Smirnov distance (AUC = 0.88), quadratic form distance (AUC = 0.87), and match distance (AUC = 0.84). These crossbin histogram distance features showed slightly higher prediction accuracy than texture features on post-PET images.
CONCLUSIONS: The results suggest that longitudinal patterns in (18)F-FDG uptake characterized using histogram distances provide useful information for predicting the pathologic response of esophageal cancer to CRT.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24089897      PMCID: PMC3785537          DOI: 10.1118/1.4820445

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  34 in total

1.  Monitoring tumor response to therapy with 18F-FLT PET.

Authors:  Wolfgang A Weber
Journal:  J Nucl Med       Date:  2010-05-19       Impact factor: 10.057

2.  An efficient Earth Mover's Distance algorithm for robust histogram comparison.

Authors:  Haibin Ling; Kazunori Okada
Journal:  IEEE Trans Pattern Anal Mach Intell       Date:  2007-05       Impact factor: 6.226

3.  Outcomes of patients with esophageal cancer staged with [¹⁸F]fluorodeoxyglucose positron emission tomography (FDG-PET): can postchemoradiotherapy FDG-PET predict the utility of resection?

Authors:  Arta Monir Monjazeb; Greg Riedlinger; Mebea Aklilu; Kim R Geisinger; Girish Mishra; Scott Isom; Paige Clark; Edward A Levine; A William Blackstock
Journal:  J Clin Oncol       Date:  2010-09-27       Impact factor: 44.544

Review 4.  Standards for PET image acquisition and quantitative data analysis.

Authors:  Ronald Boellaard
Journal:  J Nucl Med       Date:  2009-04-20       Impact factor: 10.057

5.  Detection and characterization of tumor changes in 18F-FDG PET patient monitoring using parametric imaging.

Authors:  Hatem Necib; Camilo Garcia; Antoine Wagner; Bruno Vanderlinden; Patrick Emonts; Alain Hendlisz; Patrick Flamen; Irène Buvat
Journal:  J Nucl Med       Date:  2011-03       Impact factor: 10.057

6.  Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging. The Visual Response Score and the Change in Total Lesion Glycolysis.

Authors:  Steven M. Larson; Yusuf Erdi; Timothy Akhurst; Madhu Mazumdar; Homer A. Macapinlac; Ronald D. Finn; Cecille Casilla; Melissa Fazzari; Neil Srivastava; Henry W.D. Yeung; John L. Humm; Jose Guillem; Robert Downey; Martin Karpeh; Alfred E. Cohen; Robert Ginsberg
Journal:  Clin Positron Imaging       Date:  1999-05

7.  Spatial heterogeneity in sarcoma 18F-FDG uptake as a predictor of patient outcome.

Authors:  Janet F Eary; Finbarr O'Sullivan; Janet O'Sullivan; Ernest U Conrad
Journal:  J Nucl Med       Date:  2008-11-07       Impact factor: 10.057

Review 8.  Tumor heterogeneity: causes and consequences.

Authors:  Andriy Marusyk; Kornelia Polyak
Journal:  Biochim Biophys Acta       Date:  2009-11-18

9.  Adenocarcinomas of the esophagus: response to chemoradiotherapy is associated with decrease of metabolic tumor volume as measured on PET-CT. Comparison to histopathologic and clinical response evaluation.

Authors:  Johannes B Roedl; Rivka R Colen; Nagaraj S Holalkere; Alan J Fischman; Noah C Choi; Michael A Blake
Journal:  Radiother Oncol       Date:  2008-08-11       Impact factor: 6.280

10.  Pre-therapy 18F-FDG PET quantitative parameters help in predicting the response to radioimmunotherapy in non-Hodgkin lymphoma.

Authors:  Thomas Cazaentre; Franck Morschhauser; Maximilien Vermandel; Nacim Betrouni; Thierry Prangère; Marc Steinling; Damien Huglo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-09-30       Impact factor: 9.236

View more
  13 in total

Review 1.  Computerized PET/CT image analysis in the evaluation of tumour response to therapy.

Authors:  W Lu; J Wang; H H Zhang
Journal:  Br J Radiol       Date:  2015-02-27       Impact factor: 3.039

2.  Positron emission tomography/computerized tomography for tumor response assessment-a review of clinical practices and radiomics studies.

Authors:  Wei Lu; Wengen Chen
Journal:  Transl Cancer Res       Date:  2016-08       Impact factor: 1.241

3.  Adaptive region-growing with maximum curvature strategy for tumor segmentation in 18F-FDG PET.

Authors:  Shan Tan; Laquan Li; Wookjin Choi; Min Kyu Kang; Warren D D'Souza; Wei Lu
Journal:  Phys Med Biol       Date:  2017-06-12       Impact factor: 3.609

4.  The emerging field of radiomics in esophageal cancer: current evidence and future potential.

Authors:  Peter S N van Rossum; Cai Xu; David V Fried; Lucas Goense; Laurence E Court; Steven H Lin
Journal:  Transl Cancer Res       Date:  2016-08       Impact factor: 1.241

5.  Predictive value of initial FDG-PET features for treatment response and survival in esophageal cancer patients treated with chemo-radiation therapy using a random forest classifier.

Authors:  Paul Desbordes; Su Ruan; Romain Modzelewski; Pascal Pineau; Sébastien Vauclin; Pierrick Gouel; Pierre Michel; Frédéric Di Fiore; Pierre Vera; Isabelle Gardin
Journal:  PLoS One       Date:  2017-03-10       Impact factor: 3.240

6.  Characterizing Trastuzumab-Induced Alterations in Intratumoral Heterogeneity with Quantitative Imaging and Immunohistochemistry in HER2+ Breast Cancer.

Authors:  Anum K Syed; Ryan Woodall; Jennifer G Whisenant; Thomas E Yankeelov; Anna G Sorace
Journal:  Neoplasia       Date:  2018-11-23       Impact factor: 5.715

Review 7.  Receptor-interacting protein in malignant digestive neoplasms.

Authors:  Lilong Zhang; Wenyi Guo; Jia Yu; Chunlei Li; Man Li; Dongqi Chai; Weixing Wang; Wenhong Deng
Journal:  J Cancer       Date:  2021-05-19       Impact factor: 4.207

8.  A new assessment model for tumor heterogeneity analysis with [18]F-FDG PET images.

Authors:  Ping Wang; Wengui Xu; Jian Sun; Chengwen Yang; Gang Wang; Yu Sa; Xin-Hua Hu; Yuanming Feng
Journal:  EXCLI J       Date:  2016-01-28       Impact factor: 4.068

9.  Pre-Chemoradiotherapy FDG PET/CT cannot Identify Residual Metabolically-Active Volumes within Individual Esophageal Tumors.

Authors:  W Lu; S Tan; W Chen; S Kligerman; S J Feigenberg; H Zhang; M Suntharalingam; M Kang; W D D'Souza
Journal:  J Nucl Med Radiat Ther       Date:  2015-04-29

10.  Report on the development and application of PET/CT in mainland China.

Authors:  Yumei Chen; Ruohua Chen; Xiang Zhou; Jianjun Liu; Gang Huang
Journal:  Oncotarget       Date:  2017-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.